Approval · Notice of Compliance 1535 · 2000
MELLARIL: Notice of Compliance 1535
Issued October 5, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1535
- Date
- October 5, 2000
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Tranquillizer - antipsychotic
Products in this notice
Medicinal ingredients
- THIORIDAZINE 10 MG per 5ML
- THIORIDAZINE 30 MG per ML